You are here

Medicare

Private Medicare plans must cover Biogen's ALS drug, US agency says

Yahoo/Reuters

Thu, 12/12/24 - 11:45 pm

Big pharma pushes Trump team to ease Medicare drug price negotiation rules

MSN/Reuters

Wed, 11/27/24 - 10:02 pm

Biden administration pushes anti-obesity drug pressure to Trump

Axios

Wed, 11/27/24 - 11:33 am

Biden proposes Medicare and Medicaid cover weight loss drugs

Axios

Tue, 11/26/24 - 09:51 am

RFK Jr. considers upheaval to US Medicare doctors’ billing system

Financial Times

Wed, 11/20/24 - 08:49 pm

Robert F Kennedy Jr.

Trump nominates Dr. Oz to lead Centers for Medicare and Medicaid Services

Medical Marketing and Media

Tue, 11/19/24 - 07:12 pm

Future of Medicare drug price negotiations under new administration: 5 things to know

Beckers Hospital Review

Tue, 11/19/24 - 10:59 am

Inflation Reduction Act

Trump’s win could accelerate the privatization of Medicare

NPR

Thu, 11/7/24 - 11:54 pm

Wall Street looking for CVS to show execution plan

Yahoo/Reuters

Tue, 11/5/24 - 11:17 am

Medicare coverage of weight loss drugs would cost $35B: CBO

The Hill

Wed, 10/9/24 - 08:56 pm

US releases preliminary list of $2 generic drugs for Medicare recipients

Reuters

Wed, 10/9/24 - 11:15 am

Medicare Issues Updated Rules for Second Round of Drug Negotiations

US News and World Report

Wed, 10/2/24 - 09:49 pm

Inflation Reduction Act

ICER mulls GSK COPD drugs ahead of next Medicare negotiation

Pharmaphorum

Thu, 09/19/24 - 09:21 am

Amgen Plans Phase III Program for Next-Gen Obesity Drug Targeting Liver and Kidney Diseases

BioSpace

Thu, 09/5/24 - 11:40 am

US will still pay at least twice as much after negotiating drug prices

Reuters

Tue, 09/3/24 - 11:21 am

Inflation Reduction Act

IRA biosimilar measure intended to boost uptake so far has 'limited' impact: report

Fierce Pharma

Fri, 08/30/24 - 11:25 am

Inflation Reduction Act

Feds killed plan to curb medicare advantage overbilling after industry opposition

Medical Marketing and Media

Wed, 08/28/24 - 11:35 am

Medicare Coverage of Novo’s Semaglutide for CVD Could Cost $145B Annually: Study

BioSpace

Tue, 08/27/24 - 11:32 am

cardiovascular disease

Pharmas’ IRA court losses mount. They keep pursuing them.

Pharma Voice

Mon, 08/26/24 - 11:01 am

Inflation Reduction Act

Ozempic on Wall Street's list for 2027 Medicare drug negotiations

Reuters

Fri, 08/23/24 - 10:59 am

Pages